DNA

Ginkgo Bioworks Holdings, Inc.
Data: 2026-08-21

Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Quick Stats
Aug 21, 2026

51.5

AI Score

HOLD

1.37

Volume Ratio

TBA

Next Earnings

11

+ve Days (30d)

17

-ve Days (30d)

DNA Stock Summary

Last updated Aug 21, 2026

DNA is currently trading at $7.4, positioned below its 200-day moving average of $8.42, suggesting bearish momentum. The stock has a 52-week range of $5.37 to $17.58.

Technical Analysis: The 50-day moving average stands at $8.45, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 46.244, suggesting the stock is neutral with balanced momentum.

Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.06, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates DNA at 51.5/100 with a HOLD recommendation.

DNA (Ginkgo Bioworks Holdings, Inc.) Indicators

Last updated Aug 21, 2026

Indicator Value
RSI(14) 46.244
CMF (20) -0.06
ROC (10) -7.152
ADX (14) 21.716
Indicator Value
MACD (12,26,9) -0.381
AROONOSC (14) -64.286
WILLAMS %R (14) -70.755
MFI (14) 38.53
DNA Technical Chart
  • Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
  • SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
  • Options OI: Shows max open interest strikes. High OI = significant price levels.
  • Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
  • Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
  • Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
  • Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
  • Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators

Select indicators above to analyze technical patterns

Indicators will appear below the price chart with perfectly aligned dates

Volume Profile Analysis

Horizontal histogram showing volume distribution at each price level with buying/selling pressure

DNA Price vs Max Options Open Interest
DNA Max Change In Options Open Interest

DNA Options - Sort by Max open Interest (near term)

24th August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

DNA Daily Out of Money Options - Sort by Max open Interest (near term)

24th August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

DNA Daily In the Money Options - Sort by Max open Interest (near term)

24th August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike OI Change in
OI
Volume Ask PC Delta Vega Volatility % change Track

DNA Most Active Options by Volume(near term)

24th August 2026 (Data is delayed in normal mkt. hours)

Type Expiration Strike Volume OI Change in
OI
Ask PC Delta Vega Volatility % change Track

Ginkgo Bioworks Holdings, Inc. is below both the 50 Day and 200 Day SMA which is considered Bearish.

DNA Moving Averages Analysis

DNA (Ginkgo Bioworks Holdings, Inc.) Simple Moving Averages

Moving Averages are last updated Aug 21, 2026

Days MA
10 7.19
20 7.75
30 7.9
50 8.45
100 8.3
200 8.42

DNA Fundamental Analysis

P/E (Forward) --
P/E (Trailing) --
Market Cap ($) 468.7 million
Earnings/Share ($) -5.33
Net Profit Margin (%) -2.1961
Dividend/Share ($) --
EPS Estimate Current Year ($) -3.2
EPS Estimate Next Year ($) -2.9
WallStreet Target Price ($) 7.00
Most Recent Quarter